KITD816V induces SRC-mediated tyrosine phosphorylation of MITF and altered transcription program in melanoma

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

The oncogenic D816V mutation of the KIT receptor is well characterized in systemic mastocytosis and acute myeloid leukemia. Although KITD816V has been found in melanoma, its function and involvement in this malignancy is not understood. Here we show that KITD816V induces tyrosine phosphorylation of MITF through a triple protein complex formation between KIT, MITF, and SRC family kinases. In turn, phosphorylated MITF activates target genes that are involved in melanoma proliferation, cellcycle progression, suppression of senescence, survival, and invasion. By blocking the triple protein complex formation, thus preventing MITF phosphorylation, the cells became hypersensitive to SRC inhibitors. We have therefore delineated a mechanism behind the oncogenic effects of KITD816V in melanoma and provided a rationale for the heightened SRC inhibitor sensitivity in KITD816V transformed cells. Implications: This study demonstrates that an oncogenic tyrosine kinase mutant, KITD816V, can alter the transcriptional program of the transcription factor MITF in melanoma.

Detaljer

Författare
Enheter & grupper
Externa organisationer
  • University of Oxford
  • Skåne University Hospital
  • University of Iceland
  • University of Copenhagen
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Cancer och onkologi

Nyckelord

Originalspråkengelska
Sidor (från-till)1265-1274
Antal sidor10
TidskriftMolecular Cancer Research
Volym15
Utgivningsnummer9
StatusPublished - 2017 sep 1
PublikationskategoriForskning
Peer review utfördJa